CYTOVAC A/S: Financial statements 2014
CVR: 31262666
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -8,077,959 and a net result of DKK -10,783,238 compared with DKK -10,883,498 the year before. Equity in the 2014 report amounted to DKK 18,149,542. The solvency ratio was 89.6%.
- Gross Profit
- DKK -8,077,959
- Profit/Loss
- DKK -10,783,238
- Equity
- DKK 18,149,542
- Total Assets
- DKK 20,248,296
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -8.1M | -10.8M | 18.1M | - |
| 2013 | - | -6.6M | -10.9M | 1.9M | - |
| 2012 | - | -5.2M | -10.9M | 12.8M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 21, 2014, Jørgen Kirkegaard Kimø has joined the board of directors of CYTOVAC A/S.
As of October 21, 2014, Jan Kuhlmann Andersen is registered as chairman of CYTOVAC A/S.
CYTOVAC A/S has published its annual report for 2013. Gross profit came to DKK -6,550,897, and the net result was DKK -10,883,498.
As of May 27, 2014, Ole Sylvester-Hvid Wiborg has joined the board of directors of CYTOVAC A/S.
As of May 20, 2014, Jarne Elleholm has left the board of directors of CYTOVAC A/S.
About CYTOVAC A/S
CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.